Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
80.69
-0.30 (-0.37%)
At close: Nov 7, 2025, 4:00 PM EST
80.71
+0.02 (0.02%)
After-hours: Nov 7, 2025, 6:03 PM EST

Inhibrx Biosciences Revenue

Inhibrx Biosciences had revenue of $1.30M in the quarter ending June 30, 2025, with 1,200.00% growth. This brings the company's revenue in the last twelve months to $1.40M, down -24.45% year-over-year. In the year 2024, Inhibrx Biosciences had annual revenue of $200.00K, down -88.89%.

Revenue (ttm)
$1.40M
Revenue Growth
-24.45%
P/S Ratio
834.88
Revenue / Employee
$8,696
Employees
161
Market Cap
1.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024200.00K-1.60M-88.89%
Dec 31, 20231.80M485.00K36.88%
Dec 31, 20221.32M--